These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Sensory and autonomic nerve changes in the monosodium glutamate-treated rat: a model of type II diabetes. Morrison JF; Shehab S; Sheen R; Dhanasekaran S; Shaffiullah M; Mensah-Brown E Exp Physiol; 2008 Feb; 93(2):213-22. PubMed ID: 17911358 [TBL] [Abstract][Full Text] [Related]
10. [Effect of Mudan Granule on islets beta cell function in monosodium glutamate induced obese mice with insulin resistance: an experimental study]. Liu SN; Sun SJ; Liu Q; Hou SC; Shen ZF Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Jul; 34(7):853-8. PubMed ID: 25137853 [TBL] [Abstract][Full Text] [Related]
11. Decreased incidence of diabetes mellitus by monosodium glutamate in the non-obese diabetic (NOD) mouse. Nakajima H; Tochino Y; Fujino-Kurihara H; Yamada K; Gomi M; Tajima K; Kanaya T; Miyazaki A; Miyagawa J; Hanafusa T Res Commun Chem Pathol Pharmacol; 1985 Nov; 50(2):251-7. PubMed ID: 3909273 [TBL] [Abstract][Full Text] [Related]
12. Turnover of acinar and islet cells in the pancreas of monosodium glutamate-treated obese mice. Nakayama D; Magami Y; Azuma T; Inokuchi H; Furukawa M; Ohyashiki J; Yoshimoto T; Mizuguchi J; Moriyasu F; Kawai K; Hattori T Obes Res; 2003 Jan; 11(1):87-94. PubMed ID: 12529490 [TBL] [Abstract][Full Text] [Related]
13. Cross-fostering reduces obesity induced by early exposure to monosodium glutamate in male rats. Miranda RA; da Silva Franco CC; de Oliveira JC; Barella LF; Tófolo LP; Ribeiro TA; Pavanello A; da Conceição EP; Torrezan R; Armitage J; Lisboa PC; de Moura EG; de Freitas Mathias PC; Vieira E Endocrine; 2017 Jan; 55(1):101-112. PubMed ID: 27116693 [TBL] [Abstract][Full Text] [Related]
14. Effects of bezafibrate in nonalcoholic steatohepatitis model mice with monosodium glutamate-induced metabolic syndrome. Sasaki Y; Shimada T; Iizuka S; Suzuki W; Makihara H; Teraoka R; Tsuneyama K; Hokao R; Aburada M Eur J Pharmacol; 2011 Jul; 662(1-3):1-8. PubMed ID: 21549692 [TBL] [Abstract][Full Text] [Related]
15. Anorexigenic lipopeptides ameliorate central insulin signaling and attenuate tau phosphorylation in hippocampi of mice with monosodium glutamate-induced obesity. Špolcová A; Mikulášková B; Holubová M; Nagelová V; Pirnik Z; Zemenová J; Haluzík M; Železná B; Galas MC; Maletínská L J Alzheimers Dis; 2015; 45(3):823-35. PubMed ID: 25624414 [TBL] [Abstract][Full Text] [Related]
16. Combined Administration of Monosodium Glutamate and High Sucrose Diet Accelerates the Induction of Type 2 Diabetes, Vascular Dysfunction, and Memory Impairment in Rats. Saikrishna K; Kumari R; Chaitanya K; Biswas S; Nayak PG; Mudgal J; Kishore A; Nandakumar K J Environ Pathol Toxicol Oncol; 2018; 37(1):63-80. PubMed ID: 29773001 [TBL] [Abstract][Full Text] [Related]
17. Impaired muscarinic type 3 (M3) receptor/PKC and PKA pathways in islets from MSG-obese rats. Ribeiro RA; Balbo SL; Roma LP; Camargo RL; Barella LF; Vanzela EC; de Freitas Mathias PC; Carneiro EM; Boschero AC; Bonfleur ML Mol Biol Rep; 2013 Jul; 40(7):4521-8. PubMed ID: 23652999 [TBL] [Abstract][Full Text] [Related]
18. Glibenclamide treatment blocks metabolic dysfunctions and improves vagal activity in monosodium glutamate-obese male rats. Franco CCS; Prates KV; Previate C; Moraes AMP; Matiusso CCI; Miranda RA; de Oliveira JC; Tófolo LP; Martins IP; Barella LF; Ribeiro TA; Malta A; Pavanello A; Francisco FA; Gomes RM; Alves VS; Moreira VM; Rigo KP; Almeida DL; de Sant Anna JR; Prado MAAC; Mathias PCF Endocrine; 2017 May; 56(2):346-356. PubMed ID: 28233096 [TBL] [Abstract][Full Text] [Related]